This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Ronen Tchelet, PhD
CSO at Dyadic International, Inc.


Dr. Tchelet received his Ph.D. in Molecular Microbiology and Biotechnology from Tel Aviv University in 1993 and did his postdoctoral as EERO fellow at the Institute of Environmental Science and Technology (EAWAG) in Switzerland.
Dr. Ronen Tchelet joined Dyadic in May 2014. From 2007 through 2014, prior to joining Dyadic, Dr. Tchelet was the founder and the Managing Director of Codexis Laboratories Hungary kft. (CLH) and a Vice President of Codexis Inc. At CLH, he established a state-of-the-art laboratory for strain engineering and all aspects of fermentation work including process optimization and scaling up. It was during this time period that Dr. Tchelet was engaged with the C1 technology that was successfully developed for the Biofuel and the Bio-Industrial enzymes fields.
Dr. Tchelet acquired his experience in the pharmaceutical industry when he joined the API Division of TEVA Pharmaceutical Industries LTD in the late 2000’s. At Teva, he served as a Chief Technology Officer of Biotechnology where he leaded and directed the Research and Development Biotechnology department of TEVA’s fermentation plant in Hungary. Simultaneously to this position, from 2000 – 2005, Dr. Tchelet was the QA manager of COPAXONE® the flag ship TEVA¹s innovative drug.